Cancer Family
Secondary Neoplasm
CI-CAN-00000050Explore in graph →
Non-malignant4,271 active trials56 approved drugs532 evidence items
- NCIt
- C36255
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000050Explore in graph →
Provenance
Every source that supplied a code, alias, edge, observation or derived value, with the ingest runs involved.
| Source | License | Contributions | Ingest runs | Last retrieved |
|---|---|---|---|---|
| cBioPortal for Cancer Genomics (public studies) cbioportal | approved | Genomic Cohorts | — | Sep 8, 2026, 01:25 PM UTC |
| CIViC — Clinical Interpretation of Variants in Cancer civic | approved | Evidence | ING-CIVIC-20260930-000001 | Sep 30, 2026, 02:02 AM UTC |
| EMA — European public assessment reports (centrally authorised medicines) ema | approved | Approvals | — | Sep 16, 2026, 05:01 AM UTC |
| NCI Genomic Data Commons (open aggregated data) gdc | approved | Genomic Cohorts | — | Sep 8, 2026, 10:06 AM UTC |
| NCI Thesaurus (NCIt) ncit-evs | approved | Aliases, Codes, Description, Hierarchy, Source Records | ING-NCITEVS-20260908-000001 | Sep 8, 2026, 09:44 AM UTC |
| openFDA — Drugs@FDA applications and drug labels (SPL) openfda | approved | Approvals | — | Sep 28, 2026, 04:06 AM UTC |
Identifiers
Every upstream identifier is kept with its match type; nothing is buried in JSON.
Names
| Alias | Type | Terminology | Language |
|---|---|---|---|
| Secondary Neoplasm | preferred | NCIt | en |
| Neoplasm, secondary | synonym | NCIt | en |
| Secondary Tumor | synonym | NCIt | en |
| Tumor, secondary | synonym | NCIt | en |
Change history
Creation, updates, merges and ranking changes recorded for this entity.